Opun Nasal Drops
By Opun
10ml Nasal Drops in a Packet

Composition
Xylometazoline(1.4% w/v)

Manufacturer - Nitro Organics
B-37A, Rajiv Nagar Opp. Sec.-22, Rohini, Begum Pur, Delhi-86 (INDIA)

Expires on or after
October, 2025

liver
For the safety of your liver while using Opun Nasal Drops, it is important to note that no interactions have been found or established with this product. This means that there is no known information suggesting any specific concerns regarding the impact of Opun Nasal Drops on your liver. However, to ensure the best possible safety and outcomes, it is always recommended to consult with your doctor before using any new medication or product, especially if you have liver issues or concerns. Your doctor can provide you with proper guidance tailored to your individual health needs and considerations.

kidney
No interaction with kidney issues has been found or established for Opun Nasal Drops. Consult with your doctor for proper guidance before using.

alcohol
For Opun Nasal Drops, there is no known interaction with alcohol. It is important to seek medical advice if you are pregnant before using this product.

driving
Driving while using Opun Nasal Drops is considered safe as no interactions have been found or established. You can continue driving as usual without any concerns related to the use of this medication.

pregnancy
Opun Nasal Drops may not be safe to use during pregnancy. Animal studies have shown possible harm to the developing baby. Your doctor will assess the risks and benefits before recommending use. Please consult your doctor before using Opun Nasal Drops during pregnancy.

breastfeeding
Opun Nasal Drops can be used during breastfeeding as it is considered safe. Limited information indicates no significant risk to the baby.
Habit Forming | No |
Chemical Class | Phenylpropane Derivative |
Therapeutic Class | - |
Action Class | Sympthatomimmetics- alpha 1 (Nasal) |
₹36
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025